Tower Research Capital LLC TRC cut its holdings in Agilent Technologies Inc (NYSE:A) by 21.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,066 shares of the medical research company’s stock after selling 2,406 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Agilent Technologies were worth $639,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Advisors Capital Management LLC raised its holdings in Agilent Technologies by 1.5% during the 2nd quarter. Advisors Capital Management LLC now owns 51,891 shares of the medical research company’s stock worth $3,209,000 after buying an additional 759 shares during the period. SRS Capital Advisors Inc. raised its holdings in Agilent Technologies by 75.9% during the 2nd quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock worth $110,000 after buying an additional 773 shares during the period. Sterling Capital Management LLC raised its holdings in Agilent Technologies by 0.8% during the 3rd quarter. Sterling Capital Management LLC now owns 104,765 shares of the medical research company’s stock worth $7,390,000 after buying an additional 850 shares during the period. State of Alaska Department of Revenue raised its holdings in Agilent Technologies by 1.5% during the 3rd quarter. State of Alaska Department of Revenue now owns 61,196 shares of the medical research company’s stock worth $4,315,000 after buying an additional 887 shares during the period. Finally, First Republic Investment Management Inc. raised its holdings in Agilent Technologies by 5.9% during the 2nd quarter. First Republic Investment Management Inc. now owns 17,255 shares of the medical research company’s stock worth $1,067,000 after buying an additional 969 shares during the period.

NYSE A opened at $70.25 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29. The stock has a market cap of $22.92 billion, a price-to-earnings ratio of 25.18, a P/E/G ratio of 2.01 and a beta of 1.36. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $75.11.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 19th. The medical research company reported $0.81 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.07. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. The company had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the business posted $0.67 EPS. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, sell-side analysts expect that Agilent Technologies Inc will post 3.04 earnings per share for the current year.

Agilent Technologies declared that its board has authorized a stock buyback plan on Monday, November 19th that allows the company to buyback $1.75 billion in outstanding shares. This buyback authorization allows the medical research company to reacquire up to 8.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be paid a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.93%. The ex-dividend date is Friday, December 28th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.15. Agilent Technologies’s payout ratio is 21.51%.

In other Agilent Technologies news, insider Dominique Grau sold 8,902 shares of Agilent Technologies stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $74.00, for a total transaction of $658,748.00. Following the transaction, the insider now owns 103,387 shares of the company’s stock, valued at approximately $7,650,638. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 15,923 shares of Agilent Technologies stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $73.20, for a total value of $1,165,563.60. Following the transaction, the chief executive officer now directly owns 492,546 shares in the company, valued at approximately $36,054,367.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,683 shares of company stock worth $2,499,491.

Several analysts have issued reports on A shares. Morgan Stanley boosted their price objective on Agilent Technologies from $83.00 to $84.00 and gave the stock an “overweight” rating in a report on Wednesday, August 15th. Deutsche Bank boosted their price objective on Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, August 15th. ValuEngine downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, August 18th. Goldman Sachs Group upgraded Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a report on Monday, September 17th. Finally, Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 16th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Agilent Technologies has a consensus rating of “Buy” and an average target price of $78.75.

ILLEGAL ACTIVITY WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/tower-research-capital-llc-trc-reduces-holdings-in-agilent-technologies-inc-a/2670517.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: What is Cost of Debt?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.